FDA Approves Novel Varicose Vein Treatment With Varithena

by Savitha C Muppala on  November 29, 2013 at 6:57 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

British pharmaceutical firm BTG has announced the arrival of a new treatment for varicose veins.

The company's product, Varithena, offers a minimally invasive treatment that is capable of dissolving the veins without the need for surgery.
 FDA Approves Novel Varicose Vein Treatment With Varithena
FDA Approves Novel Varicose Vein Treatment With Varithena

Varithena has received the FDA approval and should be available in the market in the second quarter of 2014.

This new treatment which targets both the symptoms and appearance of varicose veins employs injectible foam to dissolve the veins.

The company's chief executive Louise Makin said, "We look forward to the commercial U.S. launch in the second quarter of 2014, and to continuing to advance our plans to expand use into other geographies and into non-symptomatic veins."



Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Varicose Veins Deep Vein Thrombosis Modified Atkins Diet: All You Need to Know Sclerotherapy - A Treatment for Varicose Veins 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive